Government panel recommends permission for phase-III trial of Covovax as booster dose in adults
The Drugs Controller General Of India (DCGI) has already approved Covovax for restricted use in emergency situations in adults on…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Government panel recommends permission for phase-III trial of Sputnik Light vaccine as booster dose
The DCGI had on 4th February granted emergency use permission to Sputnik Light vaccine in India, subject to certain regulatory…
FDA declines paediatric EUA for Ocugen’s Covaxin
Ocugen had entered into a deal with vaccine maker Bharat Biotech in late 2020, under which it would develop, supply and…
Arthritis drug shown to reduce risk of COVID death in large UK trial
More than 8,000 patients were administered baricitinib in addition to usual care, at random, or usual care alone, as part of the…
Decision on mixing and matching of booster dose of COVID vaccines will be based on science:…
Addressing a press conference, V K Paul, member (health), NITI Aayog, said studies are going on regarding the mixing and matching…
Pfizer to provide 10 million courses of COVID-19 pill to developing countries: Global Fund
The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed to at least that many doses, and could increase…
Study finds Neem tree-based drugs may help fight against COVID
The study, led by a team from the Indian Institute of Science Education and Research, Kolkata, shows that components of Neem bark…
WHO updates its treatment guidelines to include molnupiravir
The recommendation is based on new data from six randomised controlled trials involving 4,796 patients. This is the largest…
Inovio lab tests show COVID vaccine weaker against Omicron, trial enrollment paused
Inovio has paused enrollment in the trial to prepare for this potential change, and said interim efficacy data from the trial will…
Indian, Australian researchers devise math model to predict COVID vaccine efficacy
The model can potentially optimise the use of available vaccines and speed up the development of new ones
Bahrain approves Valneva’s COVID vaccine for emergency use
Valneva expects to deliver the first shipments of its VLA2001 vaccine to the kingdom at the end of March
Pfizer/BioNTech COVID vaccine less effective in kids aged five to 11 years: New York study
The vaccine's efficacy against infection among those children declined to 12 per cent at the end of January from 68 per cent in…
Novavax expects to apply for full approval of COVID vaccine in H2
The company, late last month, filed for Emergency Use Authorisation (EUA) of the shot in US adults, a much-awaited step following…
China perseveres with mRNA COVID shot development amid Omicron, commercial uncertainty
Along with a policy of strictly containing every local outbreak, China has prevented any major virus flare-up. However, the…
SII seeks permission for phase-III study of Covovax as booster dose in adults
The Drugs Controller General Of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on 28th…
4.7 million COVID-19 vaccine doses thrown away in England by October 2021: Report
Among the vaccine jabs that were thrown away, 1.9 million doses were unused after changes to clinical advice about the AstraZeneca…
France’s Valneva expects recommendation on COVID-19 vaccine by end-March
Valneva has received a list of questions on its VLA2001 vaccine from the Committee for Medicinal Products for Human Use (CHMP) and…
Moderna and Thermo Fisher partner to manufacture COVID vaccine
As a part of the 15-year expanded deal, Thermo Fisher would provide dedicated manufacturing capacity in the US for fill/finish…
Novavax starts shipping COVID vaccine to EU states
Shipments of Nuvaxovid to additional EU member states from the company's Netherlands distribution centre are expected to quickly…
Mandaviya releases reports highlighting India’s COVID vaccination programme
The reports titled 'COVID-19 - India's Vaccine Development Story' and 'India's COVID-19 Vaccination Administration Journey'…